Key green chemistry research areas—a perspective from pharmaceutical manufacturers
GlaxoSmithKline (United Kingdom) · GlaxoSmithKline (United States) · +6 more institutions
Abstract
In 2005, the ACS Green Chemistry Institute (GCI) and the global pharmaceutical corporations developed the ACS GCI Pharmaceutical Roundtable to encourage the integration of green chemistry and green engineering into the pharmaceutical industry. The Roundtable has developed a list of key research areas. The purpose of this perspective is to summarise how that list was agreed, provide an assessment of the current state of the art in those areas and to highlight areas for future improvement.
Citation impact
- FWCI
- 26.22
- Percentile
- 100%
- References
- 77
Authors
12- DJDavid J. C. Constable
GlaxoSmithKline (United Kingdom), GlaxoSmithKline (United States)
- PJPeter J. DunnCorresponding
Pfizer (United Kingdom)
- JHJohn Hayler
GlaxoSmithKline (United Kingdom)
- GRGuy R. Humphrey
Merck & Co., Inc., Rahway, NJ, USA (United States)
- JLJohnnie L. Leazer
Merck & Co., Inc., Rahway, NJ, USA (United States)
Topics & keywords
- Pharmaceutical industry
- Key (lock)
- Perspective (graphical)
- Green chemistry
- Engineering ethics
- Business
- Nanotechnology
- Engineering management
- Industry, innovation and infrastructure